Vasoactive intestinal peptide producing tumour contains high density of somatostatin receptors.
作者信息
Reubi J C, Heitz P U, Gyr K
出版信息
Lancet. 1987 Mar 28;1(8535):741-2. doi: 10.1016/s0140-6736(87)90375-8.
PMID:2882148
Abstract
摘要
相似文献
1
Vasoactive intestinal peptide producing tumour contains high density of somatostatin receptors.
Lancet. 1987 Mar 28;1(8535):741-2. doi: 10.1016/s0140-6736(87)90375-8.
2
Secretin, cholecystokinin, and vasoactive intestinal polypeptide in pancreatic cholera.胰性霍乱中的促胰液素、胆囊收缩素及血管活性肠肽
Ann Intern Med. 1986 Oct;105(4):632. doi: 10.7326/0003-4819-105-4-632_3.
3
Mechanisms of vasoactive intestinal peptide release in short-term culture of vasoactive intestinal peptide-producing tumor.血管活性肠肽分泌肿瘤短期培养中血管活性肠肽释放的机制
Gastroenterology. 1988 Feb;94(2):513-8. doi: 10.1016/0016-5085(88)90446-5.
4
Vasoactive intestinal peptide producing neuroblastoma.产生血管活性肠肽的神经母细胞瘤
J Pediatr Surg. 1982 Dec;17(6):821-25. doi: 10.1016/s0022-3468(82)80450-8.
5
Watery diarrhea syndrome caused by multihormonal malignant pancreatic islet cell tumor secreting somatostatin, vasoactive intestinal peptide, serotonin, and prostaglandin E--a clinicopathological, biochemical, immunohistochemical, and ultrastructural study.
Pancreas. 1986;1(1):80-9. doi: 10.1097/00006676-198601000-00015.
6
Can inhibition of hormone secretion be associated with endocrine tumour shrinkage?激素分泌的抑制与内分泌肿瘤缩小有关吗？
Lancet. 1983;2(8365-66):1501. doi: 10.1016/s0140-6736(83)90847-4.
7
[Successful therapy of VIPoma with the long-acting somatostatin analogue SMS 201-995].
Nihon Naika Gakkai Zasshi. 1988 Jan;77(1):86-90. doi: 10.2169/naika.77.86.
8
Watery diarrhoea and a vasoactive intestinal peptide secreting ganglioneuroma.
Med J Aust. 1984 Jan 21;140(2):97-9. doi: 10.5694/j.1326-5377.1984.tb103905.x.
9
Pancreatic cholera syndrome: effect of a synthetic somatostatin analog on intestinal water and ion transport.
Ann Intern Med. 1985 Sep;103(3):363-7. doi: 10.7326/0003-4819-103-3-363.
10
Somatostatin and analogues in the treatment of VIPoma.
Ann N Y Acad Sci. 1988;527:528-35. doi: 10.1111/j.1749-6632.1988.tb27006.x.
引用本文的文献
1
2
The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide.恶性神经内分泌肿瘤组织中生长抑素受体的存在预示着对奥曲肽的反应性。
Yale J Biol Med. 1992 Sep-Oct;65(5):505-18; discussion 531-6.
Zotero 插件